2G·

HIMS 🚀

If you visit Hims' website, you'll see that they not only offer Zepbound, but apparently other branded GLP-1s as well, including Ozempic and Wegovy.

This probably indicates that $HIMS (+1,18%) also works with $NOVO B (-1,81%) is also working together.

2G·

BREAKING: Bloomberg reports that HIMS is partnering with Lilly to sell Zepbound through its telehealth platform 🚀

8 Commenti

Sell the News Event.

Edit: I made a post about it

•

@Ph1l1pp I think we are more likely to see new all-time highs this year ✌️ let's see in which direction it goes.

••

@Ph1l1pp I don't know how much you have been involved with the company, but the strong growth was already there before GLP-1. Good luck to you ✌️

•

@BamBamInvest I think the chart is more meaningful here
(+13% -> +5%)

Good luck to you too :)

••

@Ph1l1pp Using the daily chart as an analysis for the future development of a company is very questionable 🤣

•

@Bubu_98 the price reflects market expectations, what else should I take? 🦧

But of course I'm glad that you were early with H&H

••

@Ph1l1pp danke ✌️

••

meanwhile considering dissolving novo and putting it into hims

••